HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost

The development of a preventive vaccine against human immunodeficiency virus (HIV-1) infection is the most efficient method to control the epidemic. The ultimate goal is to develop a vaccine able to induce specific neutralizing, non-neutralizing antibodies and cellular mediated immunity (CMI). Humor...

Descripción completa

Detalles Bibliográficos
Autores principales: Apostólico, Juliana de Souza, Boscardin, Silvia Beatriz, Yamamoto, Márcio Massao, de Oliveira-Filho, Jethe Nunes, Kalil, Jorge, Cunha-Neto, Edecio, Rosa, Daniela Santoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699765/
https://www.ncbi.nlm.nih.gov/pubmed/26727218
http://dx.doi.org/10.1371/journal.pone.0145637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699765/
https://www.ncbi.nlm.nih.gov/pubmed/26727218
http://dx.doi.org/10.1371/journal.pone.0145637

Ejemplares similares